Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Weichselbaum

Showing results (81-90 of 815) with videos related to

Pageof 82
Sort By:
Cancer Research|October 1, 1980
Limited penetration of methotrexate into human osteosarcoma spheroids as a proposed model for solid tumor resistance to adjuvant chemotherapyG W West, R Weichselbaum, J B Little
Science Immunology|December 27, 2016
The intersection of radiotherapy and immunotherapy: mechanisms and clinical implicationsMichael Spiotto, Yang-Xin Fu, Ralph R Weichselbaum
The Annals of Otology, Rhinology, and Laryngology|July 1, 1982
Chemical modulation of the hypoxic fraction in the treatment of head and neck cancerR R Weichselbaum, T J Ervin, D Miller
The New England Journal of Medicine|December 21, 1978
Fallacy of the five-year survival in lung cancerB J McNeil, R Weichselbaum, S G Pauker
International Journal of Radiation Oncology, Biology, Physics|April 1, 1980
X-ray sensitivity of human tumor cells in vitroR R Weichselbaum, J Nove, J B Little
Nature|January 19, 1978
Deficient recovery from potentially lethal radiation damage in ataxia telengiectasia and xeroderma pigmentosumR R Weichselbaum, J Nove, J B Little
The New England Journal of Medicine|April 19, 1979
Preferences of patients and the fallacy of the five-year survivalB J McNeil, R Weichselbaum, S G Pauker
Nature|April 21, 1977
Skin fibroblasts from a D-deletion type retinoblastoma patient are abnormally X-ray sensitiveR R Weichselbaum, J Nove, J B Little
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2020
Radiotherapy and Immunotherapy for Cancer: From "Systemic" to "Multisite"Ainhoa Arina, Stanley I Gutiontov, Ralph R Weichselbaum
JAMA Oncology|January 6, 2022
Immunotherapy for the Neoadjuvant Management of Resectable Intrathoracic Cancers: Let's Not Forget RadiotherapyJoe Y Chang, Vivek Verma, Ralph R Weichselbaum
Pageof 82

Showing results (81-90 of 815) with videos related to

Sort By:
Pageof 82
Cancer Research|October 1, 1980
Limited penetration of methotrexate into human osteosarcoma spheroids as a proposed model for solid tumor resistance to adjuvant chemotherapyG W West, R Weichselbaum, J B Little
Science Immunology|December 27, 2016
The intersection of radiotherapy and immunotherapy: mechanisms and clinical implicationsMichael Spiotto, Yang-Xin Fu, Ralph R Weichselbaum
The Annals of Otology, Rhinology, and Laryngology|July 1, 1982
Chemical modulation of the hypoxic fraction in the treatment of head and neck cancerR R Weichselbaum, T J Ervin, D Miller
The New England Journal of Medicine|December 21, 1978
Fallacy of the five-year survival in lung cancerB J McNeil, R Weichselbaum, S G Pauker
International Journal of Radiation Oncology, Biology, Physics|April 1, 1980
X-ray sensitivity of human tumor cells in vitroR R Weichselbaum, J Nove, J B Little
Nature|January 19, 1978
Deficient recovery from potentially lethal radiation damage in ataxia telengiectasia and xeroderma pigmentosumR R Weichselbaum, J Nove, J B Little
The New England Journal of Medicine|April 19, 1979
Preferences of patients and the fallacy of the five-year survivalB J McNeil, R Weichselbaum, S G Pauker
Nature|April 21, 1977
Skin fibroblasts from a D-deletion type retinoblastoma patient are abnormally X-ray sensitiveR R Weichselbaum, J Nove, J B Little
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2020
Radiotherapy and Immunotherapy for Cancer: From "Systemic" to "Multisite"Ainhoa Arina, Stanley I Gutiontov, Ralph R Weichselbaum
JAMA Oncology|January 6, 2022
Immunotherapy for the Neoadjuvant Management of Resectable Intrathoracic Cancers: Let's Not Forget RadiotherapyJoe Y Chang, Vivek Verma, Ralph R Weichselbaum
Pageof 82